To improve diagnosis and prognosis of colorectal cancer (CRC) using a novel deep learning framework that integrates multiple data types, emphasizing the synergy of these data types.
Key Findings:
PRISM-CRC significantly outperformed single data type models, demonstrating superior predictive capabilities.
The PRISM-CRC risk score is a strong independent predictor of survival, outperforming traditional metrics.
The model allows for more granular risk stratification compared to traditional TNM staging, providing clearer insights into patient prognosis.
Interpretation:
The multimodal approach enhances clinical decision-making, particularly in identifying high-risk patients who may benefit from adjuvant chemotherapy, ultimately improving patient outcomes.
Limitations:
Performance may decrease due to 'domain shift', necessitating further research into model robustness.
Classification errors in morphologically ambiguous cases highlight the need for improved training datasets.
Conclusion:
PRISM-CRC shows promise for improving personalized treatment strategies in colorectal cancer, necessitating future prospective trials for validation to ensure clinical applicability.
